ADVERTISEMENT

From the Desk of the CEO

Community pharmacists are rewriting the rules of practice
James Keagy
/ Categories: CEO Blog

Community pharmacists are rewriting the rules of practice

Two independent pharmacists show how autonomy, transparency, and clinical care can restore joy—and sustainability—to community pharmacy

Over the past 3 years, I’ve spoken with many community pharmacists who are deeply dissatisfied with their work. The reasons are well known and don’t need repeating. What deserves more attention is what is working—and how those examples can help move our profession forward.

Recently, at the Pennsylvania Pharmacists Association meeting in Harrisburg, I met two community pharmacists who are experiencing something rarely discussed: professional fulfillment. Brandon Antinopoulos, PharmD, of Forward Rx Pharmacy and Kyle McCormick, PharmD, of Blueberry Pharmacy are building practices that look very different from the status quo—and their experiences offer a powerful lesson for the profession.

Starting with a simple goal: Serve patients without interference

Both pharmacists began with the same core motivation: a love for their communities and the patients they serve. They wanted to practice pharmacy without interference that distracted from patient care.

To do that, each adopted a cost-plus pharmacy model. They calculated the true cost of providing prescription medications, added a reasonable and transparent fee to ensure sustainability, and made that pricing public so patients could clearly understand the value being delivered. Insurance is accepted only when payers agree to those cost-plus terms.

The result? Predictability. Transparency. And control.

Predictable revenue, early profitability, and growing demand

The outcomes of this approach have been striking. I haven’t seen two pharmacists in a long time who were as calm, confident, and satisfied in their professional lives. One told me he became profitable very quickly after opening and no longer worries about when—or whether—he will be paid.

Both practices continue to grow month after month. One has established contracts with local employers to provide clinical services, while the other has built strong referral relationships with physicians in the community.

In each case, their business models don't compete with patient care—they enable it.

Practicing at the top of their training—and why it matters

These pharmacists are doing exactly what they were trained to do. Their practices are highly clinical. They intervene daily as medication therapy experts, ensuring appropriate therapy, and better outcomes—and they are paid directly for that work.

Rather than waiting for perfect conditions or system-wide reform, they defined their clinical services, set clear fees, and educated their communities about what they offer.

A major source of their professional fulfillment is control—over clinical decisions, time, and how patient needs are met. That autonomy has made a meaningful difference for both pharmacists and patients.

Many student pharmacists struggle with the tension between patient care and administrative burden. Some ultimately look outside direct care, even though caring for patients is what drew them to pharmacy in the first place.

What these two pharmacists demonstrate is that a full, rewarding career in direct patient care is already happening in communities across the country.

The path forward is already being built

Congratulations to Antinopoulos and McCormick for leading the way. Their work shows that community pharmacy does not need to abandon patient care to survive—it needs our collective encouragement to rethink how care is delivered and valued.

For every pharmacist. For all of pharmacy.

Previous Article APhA: Adding value to member’s lives
Next Article Lessons from Coach Lou Holtz
Print
6130
Please login or register to post comments.

Featured Post

Posted: Sep 29, 2026

Remembering Jack Schlegel, former APhA CEO

APhA mourns the passing of former CEO John F. “Jack” Schlegel, PharmD. His courageous leadership helped shape our association and strengthen pharmacy’s voice. Michael Hogue reflects on Jack’s legacy and the kindness he experienced firsthand.

All Posts

Posted: Oct 8, 2026

What Canada can teach us about the pharmacy team

In his latest blog, APhA CEO Michael Hogue explores how technology, pharmacy technicians, and modernized workflows can help transform pharmacy practice and enable pharmacists to focus on the patient care services only they are trained and licensed to provide. Drawing from a visit to a high-volume community pharmacy in Quebec, Hogue highlights a care model where pharmacists concentrate on medication management, clinical decision-making, and patient consultations, while technology and qualified technicians support dispensing operations.

Posted: Sep 29, 2026

Remembering Jack Schlegel, former APhA CEO

APhA mourns the passing of former CEO John F. “Jack” Schlegel, PharmD. His courageous leadership helped shape our association and strengthen pharmacy’s voice. Michael Hogue reflects on Jack’s legacy and the kindness he experienced firsthand.

Posted: Sep 17, 2026

We're all in this together

Following the passing of former APhA President R. David Cobb, APhA CEO Michael Hogue reflects on Cobb’s enduring leadership and his belief that pharmacy is strongest when its organizations work together.

Posted: Sep 14, 2026

Standard of Care Means Pharmacists Must Control Their Own Practice

As pharmacy practice continues to evolve, pharmacists must have the autonomy to exercise their professional judgment and make decisions based on the needs of their patients. In this blog, CEO Michael Hogue explains why pharmacists must control their own practice and why professional autonomy is essential to protecting patients and advancing the profession.

Posted: Sep 11, 2026

Remembering September 11, 2001

Like many of you, I remember exactly where I was when I learned that an airplane had been intentionally flown into the World Trade Center in New York. Standing behind the counter at Morgan City Drugs, I didn’t have access to a television. However, we did have a radio, and it wasn’t hard to find a station that was covering the real-time events that morning. When the second airplane hit, we all knew that this was no accident, but an intentional attack on the very freedom we hold dear.

Voices of APhA

Perspectives & Stories from Our Staff

Posted: Oct 23, 2026

Kratom’s risks deserve our attention

Brigid Groves, PharmD, MS, Vice President, Professional Affairs, APhA

A patient seeking relief may not recognize the risks of a product within easy reach. Brigid K. Groves, PharmD, MS, APhA’s Vice President, Professional Affairs, shares why kratom and concentrated 7-OH products deserve pharmacists’ attention and how a simple conversation can help protect patients from harm.

Posted: Jul 22, 2026

Congressional update: The hurry up and wait approach

Douglas Huynh, JD, Director, Congressional Affairs, APhA

In this blog, Doug Huynh provides an update on the rapidly shrinking congressional calendar and what it means for key pharmacy priorities. He explores the opportunities and challenges facing legislation such as the Main Street Pharmacy Access Act and why time may be the biggest obstacle to advancing pharmacy policy this year.

Posted: Jun 3, 2026

The bill formerly known as ECAPS

Douglas Huynh, JD, Director, Congressional Affairs, APhA

In this blog, Doug Huynh provides an inside look at recent congressional activity surrounding H.R. 3164—the “Main Street Pharmacy Access Act,” formerly known as ECAPS. He breaks down what this progress means for pharmacists, patients, and the broader healthcare system, and why this moment represents an important step toward recognizing pharmacists as essential Part B providers.

Guest Spotlights

Thought Leadership & Contributions from Industry Experts

Posted: Jul 2, 2026

Deprescribing has entered the payment era

Jennifer Pruskowski, PharmD, PhD, BCPS, BCGP and Sean M. Jeffery, PharmD, BCGP, FASCP, AGSF

For years, clinicians have known that deprescribing is clinically important. Every day, health care professionals identify unnecessary medications, reduce adverse drug events, prevent falls, minimize drug interactions, and help patients navigate medication burden.

Posted: Jun 10, 2026

Offer vaccines just as strongly as last year

Col (Ret) John D. Gräbenstein, RPh, PhD, FAPhA, Managing Editor, IZ Express, Immunize.org

In a new guest blog from APhA, Col (Ret) John D. Gräbenstein, RPh, PhD, FAPhA, encourages pharmacists to continue giving strong vaccine recommendations and reminds the profession that vaccines remain one of the safest and most effective tools to prevent serious illness and death.

Posted: Jun 8, 2026

The Importance of Motivational Interviewing and Patient Connection

Bruce A. Berger, PhD, Professor Emeritus, Auburn University Harrison College of Pharmacy

Fifteen years ago, William Villaume and I developed our sense making approach to motivational interviewing (MI) based on Brenda Dervin's sense making theory.

Advertisement
Advertisement
Advertisement
Advertisement